Nephro Care India Limited IPO

Apply 0
Avoid 0

Nephro Care, founded in 2014 by Dr. Pratim Sengupta in Kolkata, is dedicated to offering comprehensive medical services for renal patients. Positioned as a one-stop treatment center, Nephro Care specializes in a broad spectrum of clinical and lifestyle solutions, focusing on renal insufficiency treatment.

Mission and Vision

Nephro Care is driven by a commitment to provide the highest quality medical care, ensuring it is accessible and affordable for local, national, and international patients. The institution’s mission is to deliver holistic wellness through a blend of lifestyle, physiological, and spiritual treatment frameworks, underpinned by scientific rigor, transparency, and ethical practices.

Services and Solutions

Nephro Care’s range of services includes:
i. Clinical Solutions: Comprehensive medical treatments tailored for renal insufficiency and related conditions.
ii. Lifestyle Solutions: Programs aimed at improving the overall well-being of patients through lifestyle modifications.
iii. Wellness Programs: Integration of physiological and spiritual aspects to promote holistic health.

Infrastructure

Nephro Care is equipped with advanced clinical and investigative infrastructure, enabling it to deliver high-quality care. The facility includes state-of-the-art medical equipment and technology to support various diagnostic and treatment processes.

Ethical Practices

The treatment regimes at Nephro Care are meticulously planned based on core scientific principles. The institution upholds the highest standards of transparency and ethics, ensuring that patients receive reliable and trustworthy medical care.

Conclusion

Nephro Care stands out as a premier institution for renal care, thanks to its comprehensive range of services, expert team, robust infrastructure, and unwavering commitment to ethical and affordable healthcare. By integrating clinical excellence with holistic wellness approaches, Nephro Care is dedicated to improving the quality of life for renal patients.

Objects of the Nephro Care India Limited IPO:

The company intends to utilize the Net Fresh Issue Proceeds for the following Objects i. Setting up of Multi Speciality Hospital in the name of "Vivacity Multi Specialty Hospital" (unit of Nephro Care) at Kolkata (Madhyamgaram), West Bengal; and ii. General Corporate Expenses
DRHP of Nephro Care India Limited IPO
RHP of Nephro Care India Limited IPO

Nephro Care India Limited IPO Details:

Open Date: Jun 28 2024
Close Date: Jul 02 2024
Total Shares: 4,584,000
Face Value: ₹ 10 Per Equity Share
Issue Size: 41.26 Cr.
Lot Size: 1600 Shares
Issue Price: ₹ 85 - 90 Per Equity Share
Listing At: NSE Emerge
Listing Date: Jul 05 2024

Promoters And Management:

Dr. Pratim Sengupta, 48, is the Promoter and Managing Director of the Company and a renowned Nephrologist in India with over 20 years of experience, having performed more than 1,000 kidney transplants. He earned his medical degrees from R.G. Kar Medical College & Hospital and the University of Calcutta, culminating in a Doctor of Medicine in Nephrology in 2010. Dr. Sengupta has received several awards, including a Gold Medal in Ophthalmology and the “Bharat Jyoti” award for his contributions to Nephrology. He has authored over 30 scientific articles and several books on renal nutrition, yoga, and kidney care. Pritam Sengupta, aged 41 years is the Non-Executive Director of the Company. He has done his Bachelor of Science (BSc) from University of Calcutta and Bachelor of Dental Surgery (BDS) from West Bengal University of Health Sciences. Pritam Sengupta is a dentist. He is having more than 13 years of experience as a dentist. Sutapa Sen, aged 47 years, is a Non-Independent Director of the Company. She holds MBBS degree from RG Kar Medical College, Kolkata, and has done her MD in OBS and Gynaecology from University of Dibrugarh. . She is having more than 17 years of experience as a Gynaecologist.

Financials of Nephro Care India Limited IPO:

Particulars ( In Lakhs )
2021
2022
2023
9M-FY24
Revenue from Operations 182 342 1,709 1,975
Other Income 1 0.3 0.2 14
Total Revenue 183 343 1,710 1,990
Changes in inventory -1 -15 -31 17
Purchases of stock-in-trade 125 163 520 644
Employees Benefit Expenses 15 31 113 146
Other Expenses 28 151 743 664
EBITDA 16 13 365 519
OPM (%) 8.86% 3.74% 21.34% 26.09%
Depreciation & Amortisation 1 11 79 51
EBIT 15 2 286 468
Finance Cost 3 2 15 8
PBT 12 0.02 271 459
Tax 3 1 77 119
PAT 9 -1 194 340
NPM (%) 4.84% -0.29% 11.36% 17.09%
No.of Shares 164.86 164.86 164.86 164.86
EPS 0.05 -0.01 1.17 2.06

Comparison With Peers:

Note :- There are no listed companies in India that engage in a business similar to this Company.

Recommendation on Nephro Care India Limited IPO:

1. Nephro Care's services were limited to dialysis and renal outpatient services provided through third-party facilities at Sahid Khudiram Bose Hospital, Fleming Hospital, and Dreamland Hospital. During this period, the company’s revenue was primarily derived from shared agreements with these facilities. However, in December 2021, Nephro Care expanded its operations by establishing its own daycare unit at JC-18, Salt Lake. 2. Current Services: As of now, Nephro Care provides an array of services at its clinics, including: i. Inhouse Dialysis Unit                                    ii. NABL accredited inhouse Pathology iii. Inhouse Pharmacy                                      iv. Advanced diagnostic facilities v. Renal Nutrition department                        vi. Home Care services vii. Mukti (Lifestyle Support Program)         viii. Home Dialysis ix. Outpatient Services in Nephrology, Diabetology, Cardiology, Ophthalmology, and Neurology 3. SWOT Analysis: Strengths: i. Comprehensive Care                    ii. Leadership                            iii. Technological Edge iv. Professional Team                      v. Patient Privacy Weaknesses: i. Dependency on Promoter            ii. High Manpower Costs         iii. Continuous Training Needs iv. Quality Monitoring                       v. High Capital Expenditure Opportunities: i. Growing Healthcare Demand      ii. Dialysis Service Gap             iii. Hybrid Model iv. Flagship Services                         v. CKD Epidemic Threats: i. Affordability Issues                     ii. Awareness Gap                     iii. Government Schemes iv. Doctor-Patient Ratio 4. Competition: Although Nephro Care faces no direct competition due to its comprehensive range and coverage of services, it recognizes indirect competitors based on the nature of services offered. These include: i. Nephrocare Health Pvt. Ltd.             ii. Asian Institute of Nephrology & Urology iii. Hospitals with Nephrology departments 5. The Revenue has Increased from Rs.2 Crore in FY21 to Rs.17 Crores in FY23. 6. The EBITDA has Increased from 16 Lakhs in FY21 to 3.6 Crore in FY23. 7. The PAT has Increased from 9 Lakhs in FY21 to 2 Crore in FY23. 8. As per FY23, CFO/EBITDA is 0.96, As per FY24, EPS is 2.75, 9. Market Capitalization is 148 Crores & P/E is 32.7x based on FY24.

Lead Manager of Nephro Care India Limited IPO:

  1. Corporate Capital Ventures Private Limited

Registrar of Nephro Care India Limited IPO:

  1. Bigshare Services Private Limited

Company Address:

Nephro Care India Limited Flat No-1JC-18, 5th Floor Sec-III Salt lake Kolkata, Bidhan Nagar Sai Complex, North 24 Parganas -700098 Phone: +91 8017010197 Email: cs@nephrocareindia.com/ Website: https://www.nephrocareindia.com/

Discussion on Nephro Care India Limited IPO:

Leave a Reply